PER 4.29% 6.7¢ percheron therapeutics limited

Where others have failed will Atl1102 succeed ?, page-803

  1. 43 Posts.
    lightbulb Created with Sketch. 3
    Not to mention getting a cell therapy through the fda is very challenging (and particularly for small companies). Just ask any mesoblast holder...
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.